|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/13 | |
| A61K 38/21 | |||
| A61P 1/16 | |||
| A61P 31/14 |
| (11) | Patento numeris | 1778272 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05759733.8 |
| Europos patento paraiškos padavimo data | 2005-07-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-05-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-02-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2005/007633 |
| Data | 2005-07-13 |
| (87) | Numeris | WO 2006/005610 |
| Data | 2006-01-19 |
| (30) | Numeris | Data | Šalis |
| 04016583 | 2004-07-14 | EP |
| (72) |
CORNU-ARTIS, Catherine, FR
VACHON, Guylaine, CH
URYUHARA, Yoko, JP
ASAKAWA, Kazuo, JP
MERTES, Reinhild Elisabeth, DE
YOSHIBA, Shinsyou, JP
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT |
| (54) | USE OF A COMBINATION OF CYCLOSPORIN AND PEGYLATED INTERFERONS FOR TREATING HEPATITIS C (HCV) |
| USE OF A COMBINATION OF CYCLOSPORIN AND PEGYLATED INTERFERONS FOR TREATING HEPATITIS C (HCV) |